Tag: Pricing

NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, today announced the ...

MADISON, Wis., April 13, 2022 (GLOBE NEWSWIRE) -- Sonic Foundry Inc. (Nasdaq: SOFO), the trusted leader in video capture, management and streaming solutions as well as virtual and hybrid events, ...

SINGAPORE, April 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire  – Aura FAT Projects Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of $100,000,000, consisting of ...

SINGAPORE, April 11, 2022 (GLOBE NEWSWIRE) -- Genius Group Limited (“Genius Group” or the “Company”) today announced the pricing of its initial public offering of 3,272,727 ordinary shares at a ...

HOUSTON--(BUSINESS WIRE)--Camden Property Trust (NYSE:CPT) today announced it has priced a public offering of 2,900,000 common shares for gross proceeds of approximately $493 million. The offering is expected to close ...

NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel ...

PALO ALTO, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) today announced the pricing of its underwritten public offering of $2.0 billion aggregate principal amount of senior unsecured ...

MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet ...

NEW YORK--(BUSINESS WIRE)--Blackstone Mortgage Trust, Inc. (NYSE: BXMT) (the “Company”) today announced the pricing of an underwritten public offering of $300 million aggregate principal amount of its 5.50% convertible senior ...

FORT COLLINS, Colo., March 22, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a leading biopharmaceutical company creating next-generation immune therapies that focus on ...